2012 Tuberculosis Medicines Technology Landscape
Author:
Organization: UNITAID
Year: 2012
Document Type: Report
Abstract/Summary: The goal of this report is to provide TB stakeholders with an assessment of the TB medicines landscape so as to identify opportunities to improve market dynamics and ensure accessibility of safe and effective TB treatment. To understand the challenges of current and future TB treatment, this landscape analysis describes:
• The current TB medicines available to treat TB infection and disease;
• The shortcomings of current treatments and the need for new TB treatments;
• The new TB medicines being developed and how they may address current challenges in TB treatment;
• The research and regulatory challenges impacting uptake of new TB medicines and what key players are doing to address these challenges; and
Some sections in this report have been adapted from the TAG Pipeline Report 2012, which includes regularly updated review of the latest developments in TB medicines (http://www.pipelinereport.org). This UNITAID report is intended to complement the TAG Pipeline Report, with particular emphasis on market issues and treatment in low- and middle-income countries.
Disease/Therapeutic Area: Tuberculosis
Geography:
Income Classification (World Bank):
Market Shortcomings:
Focus Areas:
Interventions:
Keywords:
Global Health Market Dynamics 